Life at the Johns Hopkins School of Medicine
Ph.D. candidate Roshan Chikarmane identifies key drivers of rising drug prices and introduces corresponding interventions that are being undertaken by business leaders to shift industry trends toward more affordable health care.
The Johns Hopkins-AstraZeneca Scholars Program is a first-of-its-kind Ph.D. training program, in which students are introduced to the process and challenges of drug discovery and development through coursework in translational research and work conducted at AstraZeneca.